Leslie Citrome, MD, MPH

Letter to the Editor

The Impact of Ethnicity on Metabolic Outcomes During Treatment With Antipsychotics: Complexities Abound

November 15, 2009

Original Research

How Dosing of Ziprasidone in a State Hospital System Differs From Product Labeling

July 21, 2009

ASCP Corner

Adding Lithium or Anticonvulsants to Antipsychotics for the Treatment of Schizophrenia: Useful Strategy or Exercise in Futility?

June 18, 2009

Original Research

Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or Schizoaffective Disorder With Suboptimal Prior Response

June 2, 2009

ASCP Corner

All Antipsychotics Are Equal, but Some Are More Equal Than Others

March 16, 2009

Original Research

Comparison of Intramuscular Ziprasidone, Olanzapine, or Aripiprazole for Agitation: A Quantitative Review of Efficacy and Safety

December 14, 2007

Article

Introduction. Weighing the Evidence: Weight Management Insights for Treating Major Mental Illness

September 14, 2007

Article

The Effectiveness Criterion: Balancing Efficacy Against the Risks of Weight Gain

September 14, 2007

ASCP Corner

The Psychopharmacology of Violence With Emphasis on Schizophrenia, Part 2: Long-Term Treatment

February 15, 2007

ASCP Corner

The Psychopharmacology of Violence With Emphasis on Schizophrenia, Part 1: Acute Treatment

January 15, 2007

Original Research

Efficacy of Ziprasidone Against Hostility in Schizophrenia: Post Hoc Analysis of Randomized, Open-Label Study Data

April 15, 2006

Original Research

Dosing of Quetiapine in Schizophrenia: How Clinical Practice Differs From Registration Studies

December 15, 2005